Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges
- Kamal M.A. , et al.
2. Genomic biomarkers to guide precision radiotherapy in prostate cancer
- Sutera P. , et al.
3. Marsdenia tenacissima Extract Induces Autophagy and Apoptosis of Hepatocellular Cells via MIF/mToR Signaling
- Lin S. , et al.
4. Natural Products as PI3K/ Akt Inhibitors: Implications in Preventing Hepatocellular Carcinoma
- Narayanankutty A. , et al.
5. 2-Methoxyestradiol synergizes with Erlotinib to suppress hepatocellular carcinoma by disrupting the PLAGL2-EGFR-HIF-1/2α signaling loop
- Zheng S. , et al.
7. Expression and clinical significance of ERCC1 and XPF in human hepatocellular carcinoma
- Liao X. , et al.
8. Precise immunodetection of PTEN protein in human neoplasia
- Pulido R. , et al.
9. Progress in research on association between cell signal transduction pathways and hepatocellular carcinoma
- Chen C. , et al.
10. Ecto-5′-nucleotidase (CD73) is a potential target of hepatocellular carcinoma
- Shali S. , et al.
11. Relationship between EGFR expression and subcellular localization with cancer development and clinical outcome
- Yan G. , et al.
12. Evolving Systemic Therapy in Hepatocellular Carcinoma: Current Management and Opportunities for Integration With Radiotherapy
- Keane F.K. , et al.
14. Anti-tumor effects of NVP-BKM120 alone or in combination with MEK162 in biliary tract cancer
- Jin L. , et al.
15. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine
- Kamel H.F.M. , et al.
16. Diagnostic and prognostic values of contrast-enhanced ultrasound in breast cancer: A retrospective study
- Zhao Y.X. , et al.
17. Genetic alterations in hepatocellular carcinoma: An update
- Niu Z.S. , et al.
18. EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma
- Han C. , et al.
19. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization
- Wang X.C. , et al.
21. Search: A phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma
- Zhu A.X. , et al.
22. Hepatocellular Carcinoma: Progress in signaling pathways and therapeutic targets
- Wu J.F. , et al.
23. Epidermal growth factor receptor pathway polymorphisms and the prognosis of hepatocellular carcinoma
- Wang W. , et al.